NCT02927496View on ClinicalTrials.gov

A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali

PHASE3CompletedINTERVENTIONAL
Enrollment

220

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

December 19, 2020

Study Completion Date

December 19, 2020

Conditions
LymphedemaLymphatic FilariasisFilariasis
Interventions
DRUG

Doxycycline

"Once daily tablet for 6 weeks:~Active comparator: Doxycycline hyclate 200 mg per day x 6 weeks for patients \>50 kg or 100 mg per day for patients \<50 kg)"

DRUG

Placebo

Once daily tablet for 6 weeks. Placebo comparator: matching tablets containing no active ingredients

Trial Locations (1)

1805

International Centers for Excellence in Research-Mali, Filariasis Res. Unit., Bamako

All Listed Sponsors
collaborator

United States Agency for International Development (USAID)

FED

lead

The Task Force for Global Health

OTHER

NCT02927496 - A 24 Month Study, to Compare the Efficacy of Doxycycline vs. Placebo for Improving Filarial Lymphedema in Mali | Biotech Hunter | Biotech Hunter